- Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy. Mottolese, M., Benevolo, M., Del Monte, G., Buglioni, S., Papaldo, P., Nisticò, C., Di Filippo, F., Vasselli, S., Vici, P., Botti, C. J. Cancer Res. Clin. Oncol. (2000)